Corbin Capital Partners’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Corbin Capital Partners’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$202K	Hold	960,479	–	–	0.33%	10
2024 Q3	$183K	Sell	960,479 -308,039	-24%	-$63.4K	0.23%	11
2024 Q2	$272K	Hold	1,268,518	–	–	0.52%	13
2024 Q1	$317K	Hold	1,268,518	–	–	0.54%	16
2023 Q4	$244K	Hold	1,268,518	–	–	1.02%	11
2023 Q3	$328K	Hold	1,268,518	–	–	0.49%	11
2023 Q2	$501K	Buy	1,268,518 +711,643	+128%	+$217K	0.42%	22
2023 Q1	$173K	Hold	556,875	–	–	0.1%	37
2022 Q4	$139K	Hold	556,875	–	–	0.04%	53
2022 Q3	$248K	Hold	556,875	–	–	0.06%	61
2022 Q2	$268K	Hold	556,875	–	–	0.06%	64
2022 Q1	$340K	Buy	+556,875	New	+$304K	0.06%	76

Other funds holding DRTSW

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Corbin Capital Partners's DRTSW Position: Q4 2024 in Review

Corbin Capital Partners held its Alpha Tau Medical Warrant (DRTSW) position steady in Q4 2024 at 960,479 shares worth $202K. The position accounts for 0.33% of the portfolio, ranked #10.

Corbin Capital Partners first reported a position in DRTSW in Q1 2022 and has held it in 12 quarters since. The position peaked at $501K in Q2 2023. 26 funds tracked by Wall St. Rank hold DRTSW as of Q4 2024.

Corbin Capital Partners held 960,479 shares of Alpha Tau Medical Warrant worth $202K as of Q4 2024.
Corbin Capital Partners left its Alpha Tau Medical Warrant share count unchanged in Q4 2024.
Alpha Tau Medical Warrant made up 0.33% of Corbin Capital Partners's portfolio in Q4 2024, its #10 holding.
Corbin Capital Partners first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 12 quarters since.
Corbin Capital Partners's Alpha Tau Medical Warrant position peaked at $501K in Q2 2023.
26 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2024.

Based on Corbin Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.